Growing out of the old self: management itself says the company has quietly become a different business, and the numbers
The model's full reasoning — Q1 2024 call → NOWe need to answer YES or NO based on the transcript. The question asks: does management convey that the company today is running on a different basis than the company its reported results and reputation were built on? That is, management describes the company as having crossed, recently and substantially, into being a different kind of business than it was, while making clear that this change is not yet what the reported numbers or the outside picture reflect. We need both halves: (1) a change of basis already real, and (2) management says the record and perception lag the change. Look at the transcript. Jim Clemmer and Steve Trowbridge talk about transformation. They mention "our transformation into the Med Tech business that we want to be." They talk about Med Tech being 33% of revenue now vs 31% a year ago, and earlier they said Med Tech was 15% of revenue two years ago. They talk about divesting Dialysis and BioSentry businesses. They talk about focusing on cardiovascular disease and cancer. They talk about milestones like PRESERVE study enrollment complete, APEX PE study 75% enrolled, etc. They talk about "the next phase of our transformation is to address the scale and structural limitations of our operating footprint." They talk about "we are on a transformation here, changing our company to one that is highly differentiated by our science and technology." But does management explicitly say that the reported results or outside perception lag the change? They mention that they are providing pro forma numbers excluding divested businesses. They say "Unless otherwise noted, all financial metrics and growth rates provided during the call today will be on a pro forma basis, which excludes the impact of our divested Dialysis and BioSentry businesses in both our fiscal ‘24 and fiscal ‘23 first quarters." That is about comparability. They also say "we continue to expect to finish the year with cash balances..." etc.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| SANG | Sangoma Technologies Corporation | Q2 2024 | 2024-02-08 | D |
| WD | Walker & Dunlop, Inc. | Q2 2022 | 2022-08-09 | C+ |
| KD | Kyndryl Holdings, Inc. | Q4 2021 | 2022-03-01 | C+ |
| CAG | Conagra Brands, Inc. | Q2 2017 | 2016-12-22 | C+ |
CALX · Q1 2023 → YESThe question is whether management conveys that the company today is running on a different basis than what its reported results and reputation were built on. Both parts: a change of basis already rea...YES The transcript shows management describing the company as now operating on a fundamentally different basis—selling into a new market of broadband service providers building consolidated networks, shifting from a legacy cyclical model to sequential revenue through platforms, clouds, and managed services—while treating this as an accomplished reality today, not a future plan. They emphasize numbers like 988 BSP deployments, 865 cloud customers, and 334 managed services customers, along with three years of over 25% growth, as evidence of this new foundation already in place.
SANG · Q2 2024 → YESThe question is whether management conveys that the company today is running on a different basis than the one its reported results and reputation were built on. Both parts: a real change of basis alr...
WD · Q2 2022 → YESThe question is whether management conveys that the company today is running on a different basis than the company its reported results and reputation were built on. Specifically, two parts: a change ...